RESEARCH TRIANGLE PARK – Drug giant GSK is moving its corporate headquarters to downtown London, the company announced today.
“Our new headquarters represents an important next step for GSK,” said CEO Emma Walmsley in the announcement.
“As a global biopharma company, we are proud to call London our home and look forward to the opportunities for even closer collaboration with the city’s world-class science, academic and healthcare institutions. Our new headquarters will provide a fantastic new focal point for GSK people to meet, collaborate and ultimately deliver solutions for the urgent healthcare challenges facing the world.”
GSK operates a manufacturing plant and has other staff based in RTP.
New look GSK unveils financials: CEO disusses ‘excellent’ performance in video update
GSK cited the move as offering “closer proximity to UK capital’s fast-growing global Life Sciences hub, Knowledge Quarter and world-class academic institutions.”
It also will help “GSK achieve ambitious sustainability targets,” the company added.
The building will house some 3,000 workers and is already under construction with move-in expected in 2024.
Its current HQ is Brentford, West London. That site has already been sold, GSK noted.
The site also will house ViiV Healthcare, which has a large operation in the Triangle.
‘The new GSK’ emerges with consumer health biz spinoff – but was it the right move?
